10
It has been demonstrated that the degradation of '251-labelled insulin by rat hepatocytes is related to the binding of the hormone to an insulin-recognition site on the plasma membrane (Terris & Steiner, 1975) . Several workers (Freychet et al., 1972; Varandani, 1973; Olefsky et al., 1975) have reported the presence of insulindegrading activity in plasma-membrane fractions isolated from rat liver by the method of Neville (1968) , but the possibility has not been rigorously excluded that this activity is due to a contamination of the plasma-membrane fractions with other subcellular fractions which are known to contain insulin-degrading enzymes.
The plasma membrane of the hepatocyte is differentiated into the blood-sinusoidal, bile-canalicular and contiguous areas, and Wisher & Evans (1975) have described a procedure for isolating plasma-membrane fractions derived from each of these different areas. This method also allows the isolation of other subcellular fractions enriched in nuclei, mitochondria and lysosomes, 'microsomes' and cytosol. The insulin-degrading activities of these fractions presented in this paper were determined by measuring the formation of radioactive products soluble in 10 % trichloroacetic acid from 1251-labelled insulin. Insulin-degrading activity was also measured by immunoassay of residual insulin, by measuring the increase in fluorescamine-reactive material (Duckworth et al., 1975) and by a spectrophotometric assay for glutathione-insulin transhydrogenase (Thomas, 1973) . Each of these methods gave essentially similar results.
If an enzyme is located in the plasma membranes, then purification of these membranes should result in an increase in the specific activity of the enzyme relative to the homogenate. Fig. 1 shows the distribution among the plasma-membrane subfractions of insulin-degrading activity and four typical plasma-membrane markers, namely Relative specific activities were calculated as the ratio of the specific activity in the subfraction to that in the homogenate. The values above the bars are the combined recoveries of activity in the subfractions expressed as a percentage of total homogenate activity.
5'-nucleotidase activity, alkaline phosphodiesterase I activity, basal and glucagonstimulated adenylate cyclase activity and the binding of 12sI-labelled insulin. The mean specific activities of these plasma-membrane markers were between 10 and 40 times higher than in the initial homogenate, whereas the specific activity for insulin degradation in each of the plasma-membrane subfractions was less than that of the homogenate. Approx. 20% of the activities of 5'-nucleotidase and alkaline phosphodiesterase present in the initial homogenate were recovered in the plasma-membrane fractions. The recoveries of adenylate cyclase and of insulinbinding activity were lower, but this probably reflects a partial loss of activity during the extensive subfractionation procedure (Wisher & Evans, 1975) . In contrast, the recovery of insulin-degrading activity in the plasma-membrane subfractions was very low, being less than 0.5 %. Most of the activity was recovered in the microsomal(35 %) and cytosol fractions (25 %).
The experiment was repeated with plasma-membrane subfractions isolated by the procedure of Neville (1968) . This differs from the procedure of Wisher & Evans (1975) in that the plasma-membrane subfractions obtained are enriched in the bile-canicular and contiguous surfaces, but a large proportion of the bloodsinusoidal surface is discarded. Essentially the same pattern of results was obtained in that plasma-membrane marker enzymes and insulin-binding activity showed a high degree of purification, and again the specific activity of the insulin-degrading system fell relative to that of the initial homogenate. Similarly the percentage recovery in the plasma-membrane subfractions of the insulin-degrading activity originally present in the homogenate was very low (0.001 %) in contrast with the recovery of the plasma-membrane markers.
To test the possibility that the insulin-degrading activity of plasma membranes is due to contamination with other subcellular fractions, we compared the recovery of this activity in the plasma-membrane subfractions with the recovery of enzyme markers for the endoplasmic reticulum and cytosol. High recoveries of glucose 6-phosphatase and lactate dehydrogenase activity were obtained in the microsomal and cytosol fractions respectively, whereas insulin-degrading activity was distributed between these two fractions. The recovery, however, of each of the three enzyme activities in the plasma-membrane fractions was similar, approx. 0.5 %.
Plasma-membrane subfractions were washed by resuspending in water and then adding an equal volume of 1.8% NaCl and were separated by centrifugation. This procedure removed 72% of the lactate dehydrogenase activity, whereas only 5 % of the alkaline phosphodiesterase could be removed. Variable amounts of the insulin-degrading activity were removed by washing: up to 36% from the purified plasma-membrane subfractions, but 80 % from the crude plasma-membrane fractions. Thus it appears that only part of the contaminating insulindegrading activity in the plasma membranes is soluble.
These results show that insulin degradation by liver plasma membranes is negligible and the low activity found may be attributed to the contamination of the plasma-membrane preparations with other subcellular fractions. Thus the degradation of insulin probably involves a transfer of the hormone from a plasmamembrane binding site to an intracellular degradative site. 
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In mammals degradat ion of protohaem occurs predominantly by removal of the a-bridge resulting in the formation of biliverdin-IXa. Further reduction to bilirubin-IXa by NADPH is catalysed by biliverdin-IX reductase (O'Carra, 1975) . Cleavage at non-a-positions has been demonstrated previously by two methods.
(1) Quantification of monopyrrolic oxidative-degradation products from bilirubin showed that ox gallstones contain either 1-3 %of the y-isomer or 2-6 % of the j9-and/or 6-isomer (Tipton & Gray, 1971) . To distinguish the isomers, separation of the rubins before derivative formation is required. (2) In another approach separated biliverdin-IX derivatives are quantified. In this way, O'Carra & Colleran (1970) demonstrated that bilirubin in pig bile contains 0.4% of the B-and &isomers of bilirubin-IX. Although the different contents of non-a-isomers may reflect species variation, selective losses cannot be excluded. (a) Owing to pronounced differences in polarity between bilirubin-IX isomers (Blanckaert et al., 1976) , the most polar compound, bilirubin-1x7, and to lesser extents the 8-and &isomers could have been lost in the course of precipitation and extraction procedures applied for preparation of unconjugated bilirubin. (b) In the acid-oxidizing medium used to convert bilirubin into biliverdin, isomerization by dipyrrole exchange (Bonnett & McDonagh, 1970) may have given rise to verdin derivatives with a chromatographic behaviour different from that of the reference biliverdin-[X isomers.
To investigate the importance. and nature of the isomers of bilirubin-IX in bile, we preferred a more direct method consisting of the isolation and separation of rubin isomers. Conjugated bilirubin was first hydrolysed in alkaline medium (pH 11). After acidification to pH3 the rubins were extracted immediately into chloroform at 0°C in the presence of a 'salting-out' reagent. In the absence of the latter reagent, even at pH 3, only partial extraction of the y-isomer was obtained. Without delay the extracted pigments were separated by t.1.c. with reference to synthetic bilirubin-IX isomers. The structures of the rubins can conveniently be verified on a micro-scale by analysis of dipyrrolic azo derivatives. In this way small amounts of the 8-and &isomers, and also of the y-isomer. were demonstrated in bile of man, pig, dog and rat (about 5 % of total bilirubin-IX). They were detected only in unconjugated forms.
This observation and the differences in polarity between the bilirubin-IX isomers suggested that the modes of excretion of the non-a-isomers might be different from that of bilirubin-IXa. This hypothesis was tested in the following way. 14C-labelled bilirubin-IX isomers were injected individually into rats and their biliary excretion was studied. In Wistar rats all four isomers were excreted rapidly and at comparable rates. Complete conjugation of bilirubin-IXa and partial conjugation of the y-isomer (at least 50 %) and of the 8-and &isomers (16 %)was observed. For the latter two isomers conjugation had occurred exclusively at the carboxyl group of the propionic acid side chain of the 'inner' pyrrole ring. Gunn-strain rats were also investigated. These animals severely lack the capacity to conjugate bilirubin-IXa. In agreement with work of Lester & Klein (1966) , excretion of bilirubin-IXa was insignificant. In contrast, the non-aisomers were excreted in unconjugated forms at rates that were comparable with those found in Wistar-strain rats.
Previous conjugation of bilirubin-IXa thus appears to be obligatory for its efficient excretion, but is not a requirement itself for the other isomers. This behaviour may be
